Annual report pursuant to Section 13 and 15(d)

SEGMENT INFORMATION (Details)

v3.20.4
SEGMENT INFORMATION (Details)
$ in Thousands
12 Months Ended
Dec. 31, 2020
USD ($)
segment
Dec. 31, 2019
USD ($)
Segment Reporting Information [Line Items]    
Number of reportable segments | segment 2  
Product sales, net $ 24,429 $ 53,696
Gross profit 11,009 35,088
Research and development 2,943 5,877
Selling, general and administrative 30,658 46,451
Operating loss (22,592) (17,240)
Goodwill 2,788 2,788
Consumer Products Segment    
Segment Reporting Information [Line Items]    
Product sales, net 24,429 53,696
Gross profit 11,009 35,088
Research and development 678 2,106
Selling, general and administrative 30,547 46,405
Operating loss (20,216) (13,423)
Specialty Pharmaceutical Segment    
Segment Reporting Information [Line Items]    
Product sales, net 0 0
Gross profit 0 0
Research and development 2,265 3,771
Selling, general and administrative 111 46
Operating loss (2,376) (3,817)
Goodwill 2,800 2,800
Intangible assets $ 3,700 $ 3,800